Norway· NO-ID_A3728A58-D609-4E18-9810-938AF536FB4E
Cisatracurium Kalceks
A cisatracurium product containing cisatracurium, registered in Norway by Akciju sabiedriba Kalceks. The same ATC class is registered in 15 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Cisatracurium is registered in 15 of 19 countries.
Countries holding a registration under ATC M03AC11 (cisatracurium), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Cisatracurium · ATC M03AC11
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Cisatracurium
- Manufacturer
- Akciju sabiedriba Kalceks
- Country
- Norway (NO)
- ATC code
- M03AC11
- ATC class
- Cisatracurium
- Defined daily dose
- 10.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 5
2 priced- no_merkevare_idID_A3728A58-D609-4E18-9810-938AF536FB4E
- no_varenummer5458525 x 10NOK 401.6
- no_varenummer0465135 x 5NOK 230.9
- gtin4750341010829
- gtin4750341010812
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
89 interactions on record for cisatracurium.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cisatracurium · interactions on record
89 records
- 12 severe
- 44 moderate
- 4 minor
- 29 info
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- ParomomycinA07AA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cisatracurium in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCisatracurium Accord Healthcare 2 mg/mlAccord Healthcare
- CzechiaCISATRACURIUM KABIFresenius Kabi s.r.o., Praha
- SpainCISATRACURIO ACCORDPHARMA 2 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFGAccord Healthcare S.L.U.
- United StatesCisatracuriumFresenius Kabi USA, LLC
- FinlandCisatracurium AccordAccord Healthcare B.V.
- PolandCisatracurium AccordAccord Healthcare Polska Sp. z o.o.
- IrelandCisatracurium 2 mg/ml solution for injection/infusionNoridem Enterprises Limited
- SwedenCisatracurium Noridem 2 mg/ml Injektions-/infusionsvätska, lösningNoridem Enterprises Ltd
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Cisatracurium Accordpharma, Cisatracurium Hikma
- Belgium · Cisatracurium Fresenius Kabi, Cisatracurium Hikma
- Cyprus · Cisatracurium Accordpharma, Cisatral
- Czechia · Cisatracurium Kabi, Cisatracurium Kalceks
- Germany · Cisatracurium Hameln, Cisatracurium Hikma
- Denmark · Cisatracurium Accordpharma, Cisatracurium Fresenius Kabi
- Estonia · Cisatracurium Kalceks
- Spain · Cisatracurio Accordpharma, Cisatracurio Hikma
- Finland · Cisatracurium Accordpharma, Cisatracurium Fresenius Kabi
- France · Cisatracurium Accord, Cisatracurium Accordpharma
- United Kingdom (Northern Ireland) · Cisatracurium, Cisatracurium Accord Healthcare
- Greece · Cisatral
- Croatia · Cisatrakurij Accordpharma
- Hungary · Cisatracurium Accordpharma, Cisatracurium Kabi
- Ireland · Cisatracurium Kalceks, Cisatracurium Noridem Enterprises
- Italy · Cisatracurio Hikma, Cisatracurio Kalceks
- Lithuania · Cisatracurium Kalceks
- Luxembourg · Nimbex
- Latvia · Cisatracurium Kalceks
- Netherlands · Cisatracurium Accord, Cisatracurium Accordpharma
- Poland · Cisatracurium Accordpharma, Cisatracurium Kabi
- Portugal · Cisatracúrio Accord, Cisatracúrio Accordpharma
- Romania · Cisatracurium Noridem
- Sweden · Cisatracurium Noridem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d933bd5d-25ae-4720-afa6-ff113a343696 GET /v1/drugs/d933bd5d-25ae-4720-afa6-ff113a343696?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjons-/infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Cisatrakurium",
"merkevare_id": "ID_A3728A58-D609-4E18-9810-938AF536FB4E",
"name_form_strength": "Cisatracurium Kalceks inj/inf, oppl 2 mg/ml",
"prescription_group": "C"
}See everything about cisatracurium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.